Merck delivered a strong Q4 double beat, with robust pipeline momentum and a healthy new launch cycle supporting a continued buy rating. MRK raised its price target to $130, reflecting normalized $10 ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Workers prepare an oil containment boom at Refugio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results